CMVR lesion visual acuity intraocular pressure cytomegalovirus retinitis ganciclovir intravitreal injections treatment outcomes
Conditions
Interventions
intravitreal injection of 2-
mg ganciclovir every week for 4 weeks and then every 2 weeks until resolution of CMVR lesion,intravenous injection of ganciclovir (10mg/kg/day) for 2 weeks then followed by intravitreal injection of 2
mg ganciclovir every week for 4 weeks and then every 2 weeks until resolution of CMVR lesion
Treatment,Treatment
IVTG,IVG+IVTG
Sponsors
Siriraj Development Research Fund (managed by Routine to Research:R2R)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with cytomegalovirus retinitis
Exclusion criteria
Exclusion criteria: patients with concomitant retinal inflammation patients who previously treated with ganciclovir
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resolution of CMVR lesion 24 weeks after medication Indirect ophthalmoscopic examination | — |
Secondary
| Measure | Time frame |
|---|---|
| change of visual acuity at resolution of lesion snellen visual acuity,incidence of complication during treatment clinical observation | — |
Countries
Thailand
Contacts
Public ContactPitipol Choopong
Siriraj Hospital, Mahidol University
Outcome results
None listed